PRIVIA HEALTH GROUP INC (PRVA)
US74276R1023 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to PRVA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.22. This target is 50.11% above the current price.
PRVA was analyzed by 27 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PRVA.
In the previous month the buy percentage consensus was at a similar level.
PRVA was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-30 | Baird | Initiate | Outperform |
| 2024-05-20 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-01 | Stifel | Maintains | Buy -> Buy |
| 2024-04-22 | Citigroup | Initiate | Buy |
| 2024-03-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-06 | Barclays | Initiate | Equal-Weight |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-01 | TD Cowen | Maintains | Outperform -> Outperform |
| 2024-03-01 | UBS | Maintains | Buy -> Buy |
| 2024-02-29 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-28 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-02-22 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-12-06 | JMP Securities | Initiate | Market Outperform |
| 2023-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-18 | UBS | Maintains | Buy -> Buy |
| 2023-08-15 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-06-22 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-06-13 | Evercore ISI Group | Initiate | Outperform |
| 2023-05-08 | Credit Suisse | Reiterate | Outperform |
| 2023-04-12 | Stephens & Co. | Initiate | Overweight |
| 2023-03-10 | RBC Capital | Initiate | Outperform |
| 2023-03-07 | Credit Suisse | Reiterate | Outperform |
| 2023-02-03 | Goldman Sachs | Initiate | Buy |
| 2022-12-09 | Stifel | Initiate | Buy |
| 2022-12-08 | UBS | Initiate | Buy |
| 2022-11-11 | SVB Leerink | Maintains | Outperform |
| 2022-11-11 | Canaccord Genuity | Maintains | Buy |
| 2022-08-25 | Canaccord Genuity | Maintains | Buy |